Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder-Reference-Cited by-同舟云学术

Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder

Published:2022-11 Issue: Volume:64 Page:63-71
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Buitelaar J.K.^ORCID,van de Loo-Neus G.H.H.^ORCID,Hennissen L.,Greven C.U.,Hoekstra P.J.^ORCID,Nagy P.^ORCID,Ramos-Quiroga A.,Rosenthal E.,Kabir S.,Man K.K.C.^ORCID,IC Wong,Coghill D.^ORCID,Häge Alexander,Banaschewski Tobias,Inglis Sarah K.,Carucci Sara,Danckaerts Marina,Dittmann Ralf W.,Falissard Bruno,Garas Peter,Hollis Chris,Konrad Kerstin,Kovshoff Hanna,Liddle Elizabeth,McCarthy Suzanne,Neubert Antje,Sonuga-Barke Edmund J.S.,Zuddas Alessandro

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference33 articles.

1. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents;Polanczyk;J. Child Psychol. Psychiatry,2015

2. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder;Faraone;Neurosci. Biobehav. Rev.,2021

3. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies;Faraone;Psychol. Med.,2006

4. Attention-deficit hyperactivity disorder: diagnosis and management,2018

5. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis;Cortese;The lancet Psychiatry,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatments in the pipeline for attention-deficit/hyperactivity disorder (ADHD) in adults;Neuroscience & Biobehavioral Reviews;2024-08

2. ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines;European Child & Adolescent Psychiatry;2024-04-25

3. Trigenic COL4A3/COL4A4/COL4A5 Pathogenic Variants in Alport Syndrome: A Case Report;Nephron;2024-03-28

4. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

5. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases;JAMA Psychiatry;2023-11-22